A new blood test was found to detect colon cancer with more than 80% accuracy — and to rule it out for 90% of healthy people.

Researchers investigated immune-related adverse effects and characteristics that may predict their incidence in patients receiving ICIs for gastrointestinal cancers.

NFL star Randy Moss has given fans a health update in his first major appearance since he revealed last December that he had ...

"Was their exposure part of it, or not?" Experts are concerned by the rising trend of a type of cancer in younger people: 'We ...

Vyloy, a monoclonal antibody, is approved for use with chemotherapy to treat advanced cases of gastroesophageal junction adenocarcinoma, a rare type of GI cancer. The Japanese pharma company’s ...

Researchers explored the link between cancer stage at diagnosis and survival outcomes for non-Hispanic Black patients with gastrointestinal cancers.

Three trials presented at ASCO GI 2025 will change practice and improve the treatment of colorectal cancer, according to experts.

Adults with primary primary appendiceal adenocarcinoma face a higher risk of developing a second primary cancer, including colorectal and prostate cancers.

with gastrointestinal cancers leading the increase. Colorectal and pancreatic cancers, two of the top three deadliest cancer types, remain significant concerns as pancreatic cancer mortality continues ...

Research that has not yet been peer-reviewed shows the newest blood test is more than 80% accurate in detecting colon cancer ...

Pashtoon Kasi, MD, medical director of gastrointestinal medical ... cancer in the U.S. and the second-deadliest type, according to the Colorectal Cancer Alliance. Looking ahead, researchers ...